FDA examines liver-damage reports tied to GSK's Alli, Xenical

08/25/2009 | Google

The FDA is looking into more than 30 reports of liver damage in patients who took weight-loss drugs Alli and Xenical. The cases were reported between 1999 and October 2008. A spokeswoman for GlaxoSmithKline, which makes the treatments, said there is no proof that the products cause liver injury.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC